Explore some of our latest findings
Hudson Medical’s clinical team is committed to participating in groundbreaking research across interventional pain management, Long COVID treatment, regenerative medicine, and more.
View a few of our most recent discoveries below:
Botox-Enhanced Stellate Ganglion Blockade for the Treatment of Post-traumatic Stress Disorder
Emerging evidence promotes stellate ganglion blocks (SGB) as a treatment for post-traumatic stress disorder (PTSD) in individuals who have not fully responded to conventional therapies. Ongoing research aims to assess the reliability and sustainability of this intervention.
Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID (DSBLongCOVID)
The main purpose of this study is to gather data and assess changes in patient-reported outcomes with the stellate ganglion blocks as treatment for their sympathetically-mediated long COVID symptoms.
Which Long-COVID Treatment is Right for You?
Evidence for Stellate Ganglion Block (SGB) as a Novel Management Strategy for Anxiety Disorders
Stellate Ganglion Blocks (SGB) modulate sympathetic signaling and have been shown to provide significant and long-lasting symptom relief for patients with PTSD and trauma-related anxiety. Assuming GAD and PTSD are in some measure driven by abnormal sympathetic signaling, then SGB may have an impact on GAD symptoms.
Interventional Mental Health as a New Discipline: A Review
We hypothesize that creating unique treatment algorithm combining current therapeutic modalities such as Stellate Ganglion Blocks (SGB), Transcranial Magnetic Stimulation (TMS) therapy, and ketamine therapy, within a consolidated timeframe, will yield synergistic outcomes among patients presenting with comorbid post-traumatic stress disorder (PTSD), depression, and/or anxiety.
Dual Sympathetic Block for Post-Acute COVID-19 Syndrome (PACS)
Post-Acute COVID-19 Syndrome (PACS), commonly known as long-haul COVID or long COVID, is a new disease state characterized by the presence of persistent symptoms that affects patients who have recovered from acute infection by the SARS-CoV-2 virus. Some individuals infected with COVID-19 experience new, returning, or ongoing health problems following acute infection by the SARS-CoV-2 virus
Dual Sympathetic Block for PTSD
Recent neuroscience research has revealed a new therapeutic avenue for individuals with PTSD: Dual Sympathetic Blocks (DSBs). DSBs are a specialized sympathetic nerve block in which local anesthetic is injected into the right cervical sympathetic ganglion during the first appointment and the procedure is repeated on the left cervical sympathetic ganglion during the second appointment, reducing the concern of phrenic and recurrent laryngeal nerve palsy.
Reimagined healthcare, designed for you.
Experience the power of patient-centered healthcare.